World Journal of Surgery

, Volume 30, Issue 6, pp 985–991

Clinical Significance of Lymph Node Micrometastasis in Ampullary Carcinoma

  • Eiko Sakata
  • Yoshio Shirai
  • Naoyuki Yokoyama
  • Toshifumi Wakai
  • Jun Sakata
  • Katsuyoshi Hatakeyama
Article
  • 92 Downloads

Abstract

Background

This study aimed to clarify the clinical significance of lymph node micrometastasis in ampullary carcinoma.

Materials and Methods

Pancreaticoduodenectomy with regional lymphadenectomy was performed for 50 consecutive patients with ampullary carcinoma. A total of 1,283 regional lymph nodes (median, 25 per patient) were examined histologically for metastases. Overt metastasis was defined as metastasis detected during routine histologic examination with hematoxylin and eosin. Micrometastasis was defined as metastasis first detected by immunohistochemistry with an antibody against cytokeratins 7 and 8. The median follow-up period was 119 months after resection.

Results

Overt metastasis was positive in 90 lymph nodes from 27 patients. Micrometastasis was positive in 33 lymph nodes from 12 patients, all of whom also had overt nodal metastases. Patients with nodal micrometastasis had a larger number of lymph nodes with overt metastasis (median, 3.5) than those without (median, 0; P < 0.001). Overt metastasis to distant nodes (superior mesenteric nodes, para-aortic nodes) was more frequent (P = 0.001 and P = 0.038, respectively) in patients with nodal micrometastasis. Nodal micrometastasis was found to be a strong independent prognostic factor on univariate (P < 0.0001) and multivariate (relative risk, 5.085; P = 0.007) analyses. From among the 27 patients with overt nodal metastasis, the outcome after resection was significantly worse in the patients with nodal micrometastasis (median survival time of 11 months) than in those without (median survival time of 63 months; P = 0.0009).

Conclusions

Immunohistochemically detected lymph node micrometastasis indicates intensive lymphatic spread, and thus adversely affects the survival of patients with ampullary carcinoma.

References

  1. 1.
    Delcore R Jr, Connor CS, Thomas JH, et al. Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg 1989;158:593–597PubMedCrossRefGoogle Scholar
  2. 2.
    Shutze WP, Sack J, Aldrete JS. Long-term follow-up of 24 patients undergoing radical resection for ampullary carcinoma, 1953–1988. Cancer 1990;66:1717–1720PubMedGoogle Scholar
  3. 3.
    Monson JR, Donohue JH, McEntee GP, et al. Radical resection for carcinoma of the ampulla of Vater. Arch Surg 1991;126:353–357PubMedGoogle Scholar
  4. 4.
    Shirai Y, Tsukada K, Ohtani T, et al. Carcinoma of the ampulla of Vater: is radical lymphadenectomy beneficial to patients with nodal disease? J Surg Oncol 1996;61:190–194PubMedCrossRefGoogle Scholar
  5. 5.
    Talamini MA, Moesinger RC, Pitt HA, et al. Adenocarcinoma of the ampullary carcinoma of Vater. A 28-year experience. Ann Surg 1997;225:590–600PubMedCrossRefGoogle Scholar
  6. 6.
    Lee JH, Whittington R, Williams NN, et al. Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. Int J Radiat Oncol 2000;47:945–953CrossRefGoogle Scholar
  7. 7.
    Wells CA, Heryet A, Brochier J, et al. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer 1984;50:193–197PubMedGoogle Scholar
  8. 8.
    Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase–polymerase chain reaction. Cancer 1994;74:1595–1600PubMedGoogle Scholar
  9. 9.
    Hayashi N, Ito I, Nagase H, et al. Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res 1994;54:3853–3856PubMedGoogle Scholar
  10. 10.
    Maehara Y, Oshino T, Endo K, et al. Clinical significance of occult micrometastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996;119:397–402PubMedGoogle Scholar
  11. 11.
    Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997;337:1188–1194PubMedCrossRefGoogle Scholar
  12. 12.
    McGuckin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88–95PubMedGoogle Scholar
  13. 13.
    Lara J, Young S, Velilla R, et al. The relevance of occult axillary metastasis in ductal carcinoma in situ. Cancer 2003;98:2105–2113PubMedCrossRefGoogle Scholar
  14. 14.
    Gu CD, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected non-small cell lung cancer impact on recurrence and survival. Ann Surg 2002;235:133–139PubMedCrossRefGoogle Scholar
  15. 15.
    Ohta Y, Oda M, Wu J, et al. Can the tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastases. J Thorac Cardiovasc Surg 2001;122:900–906PubMedCrossRefGoogle Scholar
  16. 16.
    Glickmam JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769–778CrossRefGoogle Scholar
  17. 17.
    Natsugoe A, Mueller J, Stein HJ, et al. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Cancer 1998;83:858–866PubMedCrossRefGoogle Scholar
  18. 18.
    Ishida K, Katsuyama T, Sugiyama A, et al. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069–1076PubMedCrossRefGoogle Scholar
  19. 19.
    Cai J, Ikeguchi M, Maeta M, et al. Micrometastasis in lymph nodes and microinvasion of the muscularis propria in primary lesions of submucosal gastric cancer. Surgery 2000;127:32–39PubMedCrossRefGoogle Scholar
  20. 20.
    Sasaki M, Watanabe H, Jass JR, et al. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras. Histopathology 1998;32:199–208PubMedCrossRefGoogle Scholar
  21. 21.
    Oberg A, Stenling R, Travelin B, et al. Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum 1998;41:1244–1249PubMedCrossRefGoogle Scholar
  22. 22.
    Yokoyama N, Shirai Y, Hatakeyama K. Immunohistochemical detection of lymph node micrometastases from gallbladder carcinoma using monoclonal anticytokeratin antibody. Cancer 1999;85:1465–1469PubMedCrossRefGoogle Scholar
  23. 23.
    Nagakura S, Shirai Y, Yokoyama N, et al. Clinical significance of lymph node micrometastasis in gallbladder carcinoma. Surgery 2001;129:704–713PubMedCrossRefGoogle Scholar
  24. 24.
    Tojima Y, Nagino M, Ebata T, et al. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 2003;237:201–207PubMedCrossRefGoogle Scholar
  25. 25.
    Shirai Y, Ohtani T, Tsukada K, et al. Patterns of lymphatic spread of carcinoma of the ampulla of Vater. Br J Surg 1997;84:1012–1016PubMedGoogle Scholar
  26. 26.
    Greene FL, Page DL, Fleming ID, editors. (2002) American Joint Committee on Cancer (AJCC) Staging Manual 6th edn. Springer, Berlin Heidelberg New York, pp 151–156Google Scholar
  27. 27.
    Dimandopoulos GTH, Meissner WA. (1985) Neoplasia. In: Kissane JM, editor. Anderson’s Pathology, vol 1, 8th edn, Mosby, St. Louis, pp 514–559Google Scholar
  28. 28.
    Yamaguchi K, Nagai E, Ueki T, et al. Carcinoma of the ampulla of Vater. Aust N Z J Surg 1993;63:256–262PubMedGoogle Scholar
  29. 29.
    Todoroki T, Koike K, Yukio M, et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann Surg Oncol 2003;10:1176–1183PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2006

Authors and Affiliations

  • Eiko Sakata
    • 1
  • Yoshio Shirai
    • 1
  • Naoyuki Yokoyama
    • 1
  • Toshifumi Wakai
    • 1
  • Jun Sakata
    • 1
  • Katsuyoshi Hatakeyama
    • 1
  1. 1.Division of Digestive and General SurgeryNiigata University Graduate School of Medical and Dental SciencesNiigata CityJapan

Personalised recommendations